Immatics Nv Stock Analysis

IMTX Stock  USD 9.93  0.09  0.91%   
Below is the normalized historical share price chart for Immatics NV extending back to December 12, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Immatics stands at 9.93, as last reported on the 18th of February 2026, with the highest price reaching 9.96 and the lowest price hitting 9.67 during the day.
IPO Date
2nd of July 2020
200 Day MA
7.7798
50 Day MA
9.9358
Beta
1.361
 
Covid
 
Interest Hikes
Immatics NV holds a debt-to-equity ratio of 0.131. At this time, Immatics' Debt To Assets are fairly stable compared to the past year. Debt Ratio is likely to rise to 0.04 in 2026, whereas Net Debt is likely to drop (208.4 M) in 2026. With a high degree of financial leverage come high-interest payments, which usually reduce Immatics' Earnings Per Share (EPS).

Asset vs Debt

Equity vs Debt

Immatics' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Immatics' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Immatics Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Immatics' stakeholders.
For many companies, including Immatics, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Immatics NV, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Immatics' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book
2.666
Enterprise Value Ebitda
7.1866
Price Sales
15.5644
Shares Float
63.2 M
Wall Street Target Price
19.125
At this time, Immatics' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 840.6 M in 2026, whereas Common Stock Shares Outstanding is likely to drop slightly above 77.5 M in 2026. . At this time, Immatics' Price Earnings Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 1.23 in 2026, whereas Price To Sales Ratio is likely to drop 5.23 in 2026.
Immatics NV is undervalued with Real Value of 11.86 and Target Price of 19.13. The main objective of Immatics stock analysis is to determine its intrinsic value, which is an estimate of what Immatics NV is worth, separate from its market price. There are two main types of Immatics' stock analysis: fundamental analysis and technical analysis.
The Immatics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Immatics is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Immatics Stock trading window is adjusted to America/New York timezone.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immatics NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Immatics Stock Analysis Notes

About 19.0% of the company shares are held by company insiders. The book value of Immatics was currently reported as 4.07. The company recorded a loss per share of 1.1. Immatics NV had not issued any dividends in recent years. Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor based immunotherapies for the treatment of cancer in the United States. The company has a strategic collaboration agreement with GlaxoSmithKline Intellectual Property Development Limited to develop novel adoptive cell therapies targeting multiple cancer indications MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies Celgene Switzerland LLC to develop novel adoptive cell therapies targeting multiple cancers and Genmab AS to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 388 people. To learn more about Immatics NV call Harpreet Singh at 49 7071 5397 0 or check out https://www.immatics.com.

Immatics Quarterly Total Revenue

5.19 Million

Immatics NV Investment Alerts

Immatics NV had very high historical volatility over the last 90 days
Immatics NV currently holds about 324.38 M in cash with (158.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.0.
Over 82.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Can Immatics N.V. Equity Warrant be the next market leader - 2025 Key Highlights Consistent Income Trade Ideas - mfd.ru

Immatics Largest EPS Surprises

Earnings surprises can significantly impact Immatics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-05-12
2025-03-31-0.3325-0.367-0.034510 
2023-11-14
2023-09-30-0.36-0.320.0411 
2021-08-10
2021-06-30-0.34-0.38-0.0411 
View All Earnings Estimates

Immatics Environmental, Social, and Governance (ESG) Scores

Immatics' ESG score is a quantitative measure that evaluates Immatics' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Immatics' operations that may have significant financial implications and affect Immatics' stock price as well as guide investors towards more socially responsible investments.

Immatics Stock Institutional Investors

Shares
Sofinnova Ventures2025-06-30
2.2 M
Goldman Sachs Group Inc2025-06-30
M
Citadel Advisors Llc2025-06-30
879.2 K
Wasatch Advisors Lp2025-06-30
785.2 K
Orbimed Advisors, Llc2025-06-30
719.9 K
Aberdeen Group Plc2025-06-30
719.6 K
University Of Texas Investment Mgmt Co2025-06-30
697.4 K
Sphera Funds Management Ltd.2025-06-30
583.1 K
683 Capital Management Llc2025-06-30
540 K
T. Rowe Price Investment Management,inc.2025-06-30
18.3 M
Suvretta Capital Management, Llc2025-06-30
12 M
Note, although Immatics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Immatics Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.32 B.

Immatics Profitablity

The company has Profit Margin (PM) of (1.42) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (10.53) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $10.53.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.02  0.02 
Return On Capital Employed(0.06)(0.06)
Return On Assets 0.02  0.02 
Return On Equity 0.03  0.03 

Management Efficiency

Immatics NV has return on total asset (ROA) of (0.1623) % which means that it has lost $0.1623 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3003) %, meaning that it created substantial loss on money invested by shareholders. Immatics' management efficiency ratios could be used to measure how well Immatics manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Immatics' Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to rise to 0.02 in 2026, whereas Return On Capital Employed is likely to drop (0.06) in 2026. At this time, Immatics' Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 255.4 M in 2026, whereas Intangible Assets are likely to drop slightly above 1.4 M in 2026.
Last ReportedProjected for Next Year
Book Value Per Share 4.76  5.00 
Tangible Book Value Per Share 4.75  4.98 
Enterprise Value Over EBITDA 13.73  14.42 
Price Book Value Ratio 1.17  1.23 
Enterprise Value Multiple 13.73  14.42 
Price Fair Value 1.17  1.23 
Enterprise Value473.2 M380.3 M
Understanding the operational decisions made by Immatics management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Operating Margin
(10.53)
Profit Margin
(1.42)
Beta
1.361
Return On Assets
(0.16)
Return On Equity
(0.30)

Technical Drivers

As of the 18th of February 2026, Immatics retains the Downside Deviation of 4.27, market risk adjusted performance of 0.1733, and Risk Adjusted Performance of 0.0463. Immatics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Immatics NV Price Movement Analysis

Execute Study
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Immatics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Immatics NV. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Immatics Outstanding Bonds

Immatics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Immatics NV uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Immatics bonds can be classified according to their maturity, which is the date when Immatics NV has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Immatics Predictive Daily Indicators

Immatics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Immatics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Immatics Corporate Filings

13A
17th of February 2026
An amended filing to the original Schedule 13G
ViewVerify
13A
13th of February 2026
An amended filing to the original Schedule 13G
ViewVerify
6K
12th of January 2026
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
11th of December 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
8th of December 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
5th of December 2025
Other Reports
ViewVerify
6K
17th of November 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
13A
14th of November 2025
An amended filing to the original Schedule 13G
ViewVerify

Immatics Forecast Models

Immatics' time-series forecasting models are one of many Immatics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Immatics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Immatics Bond Ratings

Immatics NV financial ratings play a critical role in determining how much Immatics have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Immatics' borrowing costs.
Piotroski F Score
5
HealthyView
Beneish M Score
(1.78)
Possible ManipulatorView

Immatics NV Debt to Cash Allocation

As Immatics NV follows its natural business cycle, the capital allocation decisions will not magically go away. Immatics' decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Immatics NV currently holds 16.2 M in liabilities with Debt to Equity (D/E) ratio of 0.13, which may suggest the company is not taking enough advantage from borrowing. Immatics NV has a current ratio of 2.89, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Immatics' use of debt, we should always consider it together with its cash and equity.

Immatics Total Assets Over Time

Immatics Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Immatics uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Immatics Debt Ratio

    
  3.55   
It appears most of the Immatics' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Immatics' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Immatics, which in turn will lower the firm's financial flexibility.

Immatics Corporate Bonds Issued

Immatics Net Debt

Net Debt

(208.42 Million)

Immatics reported Net Debt of (198.49 Million) in 2025

About Immatics Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Immatics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Immatics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Immatics. By using and applying Immatics Stock analysis, traders can create a robust methodology for identifying Immatics entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.12  0.13 
Operating Profit Margin(0.22)(0.23)
Net Profit Margin 0.09  0.09 
Gross Profit Margin(1.08)(1.13)

Current Immatics Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Immatics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Immatics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceConsensus# of Analysts
19.13Strong Buy7Odds
Immatics NV current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Immatics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Immatics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Immatics NV, talking to its executives and customers, or listening to Immatics conference calls.
Immatics Analyst Advice Details

Immatics Stock Analysis Indicators

Immatics NV stock analysis indicators help investors evaluate how Immatics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Immatics shares will generate the highest return on investment. By understating and applying Immatics stock analysis, traders can identify Immatics position entry and exit signals to maximize returns.
Begin Period Cash Flow218.5 M
Common Stock Shares Outstanding106.8 M
Total Stockholder Equity574.8 M
Total Cashflows From Investing Activities-152.4 M
Tax Provision6.1 M
Property Plant And Equipment Net63.7 M
Cash And Short Term Investments604.5 M
Cash236.7 M
Accounts Payable10.1 M
Net Debt-220.5 M
50 Day M A9.9358
Total Current Liabilities68 M
Other Operating Expenses194.4 M
Non Current Assets Total66.6 M
Non Currrent Assets Other1.2 M
Stock Based Compensation17.6 M

Additional Tools for Immatics Stock Analysis

When running Immatics' price analysis, check to measure Immatics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics is operating at the current time. Most of Immatics' value examination focuses on studying past and present price action to predict the probability of Immatics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics' price. Additionally, you may evaluate how the addition of Immatics to your portfolios can decrease your overall portfolio volatility.